| 1 | Diabetic nephropathy – complications and treatment (10.2147/ijnrd.s40172) | Abstract References ORCID | 202.49 | 500 |
| 2 | Obesity, hypertension, and chronic kidney disease (10.2147/ijnrd.s39739) | Abstract References ORCID | 195.15 | 399 |
| 3 | Vascular access for hemodialysis: current perspectives (10.2147/ijnrd.s46643) | Abstract References ORCID | 180.62 | 255 |
| 4 | Rodent models of diabetic nephropathy: their utility and lim… (10.2147/ijnrd.s103784) | Abstract References ORCID | 175.23 | 216 |
| 5 | Dyslipidemia in patients with chronic kidney disease: etiolo… (10.2147/ijnrd.s101808) | Abstract References ORCID | 169.86 | 183 |
| 6 | Anxiety and depression in patients with end-stage renal dise… (10.2147/ijnrd.s126615) | Abstract References ORCID | 165.71 | 161 |
| 7 | Hypomagnesemia: a clinical perspective (10.2147/ijnrd.s42054) | Abstract References ORCID | 160.73 | 138 |
| 8 | Hereditary leiomyomatosis and renal cell carcinoma (10.2147/ijnrd.s42097) | Abstract References ORCID | 158.55 | 129 |
| 9 | Dialysis-related amyloidosis: challenges and solutions (10.2147/ijnrd.s84784) | Abstract References ORCID | 156.21 | 120 |
| 10 | Peritoneal dialysis-related peritonitis: challenges and solu… (10.2147/ijnrd.s123618) | Abstract References ORCID | 152.20 | 106 |
| 11 | Direct oral anticoagulants in patients with chronic kidney d… (10.2147/ijnrd.s105771) | Abstract References ORCID | 151.59 | 104 |
| 12 | Strategies to promote adherence to nutritional advice in pat… (10.2147/ijnrd.s76831) | Abstract References ORCID | 140.63 | 74 |
| 13 | Post-marketing surveillance study of the safety and efficacy… (10.2147/ijnrd.s145720) | Abstract References ORCID | 138.38 | 69 |
| 14 | Drug-induced impairment of renal function (10.2147/ijnrd.s39747) | Abstract References ORCID | 137.44 | 67 |
| 15 | Acute kidney injury: risk factors and management challenges… (10.2147/ijnrd.s104209) | Abstract References ORCID | 136.96 | 66 |
| 16 | Renal manifestations of genetic mitochondrial disease (10.2147/ijnrd.s37887) | Abstract References ORCID | 135.97 | 64 |
| 17 | AST-120 for the management of progression of chronic kidney… (10.2147/ijnrd.s41339) | Abstract References ORCID | 135.97 | 64 |
| 18 | Phosphate control in dialysis (10.2147/ijnrd.s35632) | Abstract References ORCID | 129.32 | 52 |
| 19 | Nephrolithiasis in patients with inflammatory bowel disease… (10.2147/ijnrd.s45466) | Abstract References ORCID | 129.32 | 52 |
| 20 | Tubulointerstitial disease in diabetic nephropathy (10.2147/ijnrd.s37883) | Abstract References ORCID | 128.70 | 51 |
| 21 | Incidence of and risk factors for hungry bone syndrome in 84… (10.2147/ijnrd.s47179) | Abstract References ORCID | 128.70 | 51 |
| 22 | The potential use of biomarkers in predicting contrast-induc… (10.2147/ijnrd.s105124) | Abstract References ORCID | 126.09 | 47 |
| 23 | Acute respiratory muscle weakness and apnea in a critically… (10.2147/ijnrd.s42791) | Abstract References ORCID | 125.41 | 46 |
| 24 | Efficacy and safety of iron isomaltoside (Monofer®)… (10.2147/ijnrd.s89704) | Abstract References ORCID | 124.71 | 45 |
| 25 | Blood oxygenation level-dependent MRI for assessment of rena… (10.2147/ijnrd.s42924) | Abstract References ORCID | 123.26 | 43 |
| 26 | Optimal management of primary focal segmental glomeruloscler… (10.2147/ijnrd.s126844) | Abstract References ORCID | 121.74 | 41 |
| 27 | Pediatric acute kidney injury: prevalence, impact and manage… (10.2147/ijnrd.s103785) | Abstract References ORCID | 120.15 | 39 |
| 28 | Tolvaptan in the treatment of autosomal dominant polycystic… (10.2147/ijnrd.s125942) | Abstract References ORCID | 120.15 | 39 |
| 29 | Prevention of catheter-related bloodstream infections in pat… (10.2147/ijnrd.s76826) | Abstract References ORCID | 119.33 | 38 |
| 30 | Predictors of quality of life in patients with end-stage ren… (10.2147/ijnrd.s84929) | Abstract References ORCID | 118.48 | 37 |
| 31 | Hypertension in pediatric patients with chronic kidney disea… (10.2147/ijnrd.s100891) | Abstract References ORCID | 117.62 | 36 |
| 32 | Ramadan fasting and chronic kidney disease: does estimated g… (10.2147/ijnrd.s61718) | Abstract References ORCID | 116.72 | 35 |
| 33 | Renal cell carcinoma: links and risks (10.2147/ijnrd.s75916) | Abstract References ORCID | 116.72 | 35 |
| 34 | Calcium supplementation after parathyroidectomy in dialysis… (10.2147/ijnrd.s56995) | Abstract References ORCID | 115.81 | 34 |
| 35 | Renal transplantation in patients with Alport syndrome: pati… (10.2147/ijnrd.s150539) | Abstract References ORCID | 113.89 | 32 |
| 36 | Phosphate binders for the treatment of chronic kidney diseas… (10.2147/ijnrd.s78040) | Abstract References ORCID | 113.89 | 32 |
| 37 | Update on current management of chronic kidney disease in pa… (10.2147/ijnrd.s93887) | Abstract References ORCID | 113.89 | 32 |
| 38 | The importance of the thick ascending limb of Henle&rsqu… (10.2147/ijnrd.s154000) | Abstract References ORCID | 112.89 | 31 |
| 39 | Calciphylaxis in peritoneal dialysis patients: a single cent… (10.2147/ijnrd.s115701) | Abstract References ORCID | 111.85 | 30 |
| 40 | Thrombotic microangiopathy associated with use of interferon… (10.2147/ijnrd.s30194) | Abstract References ORCID | 111.85 | 30 |
| 41 | Management of hemolytic-uremic syndrome in children (10.2147/ijnrd.s41837) | Abstract References ORCID | 111.85 | 30 |
| 42 | Fifteen years of losartan: what have we learned about losart… (10.2147/ijnrd.s7038) | Abstract References ORCID | 111.85 | 30 |
| 43 | Sleep quality, depression, and quality of life in elderly he… (10.2147/ijnrd.s36493) | Abstract References ORCID | 110.78 | 29 |
| 44 | <p>Acute kidney injury after cardiac surgery: prevalen… (10.2147/ijnrd.s167477) | Abstract References | 110.21 | 159 |
| 45 | Nutritional status among peritoneal dialysis patients after… (10.2147/ijnrd.s138047) | Abstract References ORCID | 109.68 | 28 |
| 46 | Acute kidney injury: what part do toll-like receptors play? (10.2147/ijnrd.s37891) | Abstract References ORCID | 109.68 | 28 |
| 47 | BOLD magnetic resonance imaging in nephrology (10.2147/ijnrd.s112299) | Abstract References ORCID | 108.54 | 27 |
| 48 | Role of serum cystatin-C and beta-2 microglobulin as early m… (10.2147/ijnrd.s142824) | Abstract References ORCID | 108.54 | 27 |
| 49 | <p>The Importance of Tubular Function in Chronic Kidne… (10.2147/ijnrd.s216673) | Abstract References ORCID | 108.54 | 27 |
| 50 | Proteinuria and its relation to cardiovascular disease (10.2147/ijnrd.s40522) | Abstract References ORCID | 108.54 | 27 |